James C Murray
Fondateur chez ExSight Venture Management LLC
Profil
James is a co-founder and partner at ExSight Ventures where he has helped lead the firm’s investments in nine transformative ophthalmic companies.
In addition to serving on the ExSight investment committee he helms the firm’s operations.
His duties include sourcing and evaluating early-stage companies, assisting current and prospective portfolio companies, and is responsible for the firm’s operational functions.
He serves on the board of Re-Vana Therapeutics, Ltd, a Northern Ireland ocular pharmaceuticals and drug delivery company, Usher III Initiative, a nonprofit dedicated to finding treatments for individuals with Usher III, and Nectar Services, an unaffiliated New York UCaaS company.
James is a board observer at 2C Tech, a California company pioneering nanoparticle technology to treat blinding ophthalmic disease.
Prior to co-founding ExSight Ventures, James held various positions at a New York City asset management company, eventually serving as General Counsel and Head of Strategic Initiatives.
James is admitted to practice law in the State of New York.
He is a member of the Association of the Bar of the City of New York where he serves as Chair of the Emerging Companies and Venture Capital Committee.
James received his B.A.
from Canisius College and his J.D.
from Brooklyn Law School.
Postes actifs de James C Murray
| Sociétés | Poste | Début |
|---|---|---|
ExSight Venture Management LLC
 ExSight Venture Management LLC Investment ManagersFinance ExSight Venture Management LLC is a venture capital firm founded in 2014 by James C. Murray. The firm is headquartered in New York. | Fondateur | 01/01/2014 |
Nectar Services Corp.
 Nectar Services Corp. Specialty TelecommunicationsCommunications Nectar Services Corp. engages in the development of proactive network monitoring and management software for the unified communications industry. Its products include UC management platform, UC diagnostics, perspective, US foundation and call analysis. The firm also provides consulting, implementation, training and technical support services. The company was founded by David Giangano and Frances Vinci in 2006 and is headquartered in Jericho, NY. | Directeur/Membre du Conseil | 01/12/2012 |
Re-Vana Therapeutics Ltd.
 Re-Vana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Re-Vana Therapeutics Ltd. is a specialty ocular therapeutic and British drug delivery company that focuses on developing its internal pipeline and external strategic collaborations to advance its novel drug delivery platform. In 2022, Re-Vana won the Ophthalmic Innovation Summit Retina Award in drug delivery and the Belfast Nth Ireland Chamber 2022 Award for Business Innovation. Re-Vana Therapeutics was founded in 2016 as a spin-out from Queen's University, with the main office located in Belfast, UK, and an office, Re-Vana Therapeutics, Inc., based elsewhere. The company has raised more than $17.75m to support the development of sustained release biologics. In 2019, Re-Vana secured funding from Innovate totaling more than $400k to support the development of a sustained release drug. Additionally, in 2020, the company entered into a strategic feasibility collaboration with a leading pharmaceutical company for a novel therapeutic. | Directeur/Membre du Conseil | - |
| Usher Iii Initiative , Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de James C Murray
| Sociétés | Poste | Fin |
|---|
Formation de James C Murray
| Canisius College | Undergraduate Degree |
| Brooklyn Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Nectar Services Corp.
Nectar Services Corp. Specialty TelecommunicationsCommunications Nectar Services Corp. engages in the development of proactive network monitoring and management software for the unified communications industry. Its products include UC management platform, UC diagnostics, perspective, US foundation and call analysis. The firm also provides consulting, implementation, training and technical support services. The company was founded by David Giangano and Frances Vinci in 2006 and is headquartered in Jericho, NY. | Communications |
ExSight Venture Management LLC
ExSight Venture Management LLC Investment ManagersFinance ExSight Venture Management LLC is a venture capital firm founded in 2014 by James C. Murray. The firm is headquartered in New York. | Finance |
Re-Vana Therapeutics Ltd.
Re-Vana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Re-Vana Therapeutics Ltd. is a specialty ocular therapeutic and British drug delivery company that focuses on developing its internal pipeline and external strategic collaborations to advance its novel drug delivery platform. In 2022, Re-Vana won the Ophthalmic Innovation Summit Retina Award in drug delivery and the Belfast Nth Ireland Chamber 2022 Award for Business Innovation. Re-Vana Therapeutics was founded in 2016 as a spin-out from Queen's University, with the main office located in Belfast, UK, and an office, Re-Vana Therapeutics, Inc., based elsewhere. The company has raised more than $17.75m to support the development of sustained release biologics. In 2019, Re-Vana secured funding from Innovate totaling more than $400k to support the development of a sustained release drug. Additionally, in 2020, the company entered into a strategic feasibility collaboration with a leading pharmaceutical company for a novel therapeutic. | Health Technology |
| Usher Iii Initiative , Inc. |
